Search research articles
Contact Us
Filters
Showing results (421-430 of 549) with videos related to
Page
of 55
Sort By:
Leukemia
|
September 28, 2017
Therapeutic targeting of CK2 in acute and chronic leukemias
F Buontempo, J A McCubrey, E Orsini, et al.
The Italian Journal of Gastroenterology
|
May 1, 1996
Effect of ursodeoxycholic acid on hypertransaminasaemia and bile acid composition in patients undergoing bone marrow transplantation--a double-blind randomized control study
C Clerici, K D Setchell, N O'Connell, et al.
Journal of Cellular Physiology
|
April 22, 2003
Up-regulation of nuclear PLCbeta1 in myogenic differentiation
Irene Faenza, Alberto Bavelloni, Roberta Fiume, et al.
Oncotarget
|
May 25, 2015
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells
Carolina Simioni, Alice Cani, Alberto M Martelli, et al.
Cancers
|
July 24, 2020
Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of <i>MLL</i>-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML
Annalisa Lonetti, Valentina Indio, Maria Antonella Laginestra, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 28, 2021
The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of <i>LGR5</i> and <i>Notch1</i> Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine
Francesca Paganelli, Francesca Chiarini, Annalisa Palmieri, et al.
Haematologica
|
September 5, 2001
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas
C Guglielmi, M Martelli, M Federico, et al.
British Journal of Haematology
|
June 17, 2026
Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study
L Ceriani, L Milan, L Cascione, et al.
Cells
|
July 27, 2022
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
James A McCubrey, Li V Yang, Stephen L Abrams, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 25, 2019
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors
M Mancini, S De Santis, C Monaldi, et al.
Page
of 55
Search research articles
Search
Showing results (421-430 of 549) with videos related to
Sort By:
Page
of 55
Leukemia
|
September 28, 2017
Therapeutic targeting of CK2 in acute and chronic leukemias
F Buontempo, J A McCubrey, E Orsini, et al.
The Italian Journal of Gastroenterology
|
May 1, 1996
Effect of ursodeoxycholic acid on hypertransaminasaemia and bile acid composition in patients undergoing bone marrow transplantation--a double-blind randomized control study
C Clerici, K D Setchell, N O'Connell, et al.
Journal of Cellular Physiology
|
April 22, 2003
Up-regulation of nuclear PLCbeta1 in myogenic differentiation
Irene Faenza, Alberto Bavelloni, Roberta Fiume, et al.
Oncotarget
|
May 25, 2015
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells
Carolina Simioni, Alice Cani, Alberto M Martelli, et al.
Cancers
|
July 24, 2020
Inhibition of Methyltransferase DOT1L Sensitizes to Sorafenib Treatment AML Cells Irrespective of <i>MLL</i>-Rearrangements: A Novel Therapeutic Strategy for Pediatric AML
Annalisa Lonetti, Valentina Indio, Maria Antonella Laginestra, et al.
Pharmaceuticals (Basel, Switzerland)
|
December 28, 2021
The Combination of AHCC and ETAS Decreases Migration of Colorectal Cancer Cells, and Reduces the Expression of <i>LGR5</i> and <i>Notch1</i> Genes in Cancer Stem Cells: A Novel Potential Approach for Integrative Medicine
Francesca Paganelli, Francesca Chiarini, Annalisa Palmieri, et al.
Haematologica
|
September 5, 2001
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas
C Guglielmi, M Martelli, M Federico, et al.
British Journal of Haematology
|
June 17, 2026
Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study
L Ceriani, L Milan, L Cascione, et al.
Cells
|
July 27, 2022
Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
James A McCubrey, Li V Yang, Stephen L Abrams, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 25, 2019
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors
M Mancini, S De Santis, C Monaldi, et al.
Page
of 55